Analyst Ratings for Kaleido Biosciences Inc. (KLDO)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 5.7 / 10 Percentile Rank: 62%
Rating Score: 5.7 / 10 Percentile Rank: 62%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
4/4/2022 | Chardan Capital Markets | Keay Nakae | Downgrade | Neutral (Buy) |
1.70 (N/A) |
1.70 (0.29) |
-82.94% | Details |
10/19/2021 | Morgan Stanley | Vikram Purohit | Downgrade | Underweight (Equalweight) |
3.00 (12.00) |
4.94 (0.29) |
-94.13% | Details |